NPSP Chart NPSP data by YCharts

NPS Pharmaceuticals ( NPSP): Cramer said he remains bullish on this orphan drug maker after it secured the rights to one of its drugs, Gattex, in Europe.

If you liked this article you might like

Dow Hits Intraday Record but Inflation Numbers Cause Jitters Elsewhere

Hertz Stock Tumbles as Morgan Stanley Downgrades on Valuation Concerns

Uber and Lyft Have Run Over the Car Industry

'Cloud Wars' Intensify; Staples Shows Some Staying Power -- ICYMI Friday

CarMax, Avis Still Assessing Hurricane Harvey's Catastrophe